, TNFR2 + regulatory T cells (Tregs) are a stable and highly suppressive population and are increased on anti-TNF treatment in rheumatoid arthritis (RA)

M. François-santinon-a,b, F. Batignes, J. Busato-c, B. Tost, M. Salomon-d et al., INSERM, U1125, F-93017

B. B. Aggarwal, Signalling pathways of the TNF superfamily: a double-edged sword, Nat. Rev. Immunol, vol.3, pp.745-756, 2003.

K. Akassoglou, E. Douni, J. Bauer, H. Lassmann, G. Kollias et al., Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.709-714, 2003.

A. Salazar, E. K. Cortés-hernández, A. Alemán-muench, G. R. Alberú, J. Rodríguez-aguilera et al., Methylation of FOXP3 TSDR Underlies the Impaired Suppressive Function of Tregs from Long-term Belatacept, vol.8, 2017.

S. M. Atkinson, P. A. Usher, P. H. Kvist, H. Markholst, C. Haase et al., , 2012.

, Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J mice, Arthritis Res. Ther, vol.14, p.134

F. Behrens, A. Himsel, S. Rehart, J. Stanczyk, B. Beutel et al., Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis, Ann. Rheum. Dis, vol.66, pp.1151-1156, 2007.

B. Beutler and A. Cerami, Cachectin and tumour necrosis factor as two sides of the same biological coin, Nature, vol.320, p.584, 1986.

J. Biton, L. Semerano, L. Delavallée, D. Lemeiter, M. Laborie et al., Interplay between TNF and Regulatory T Cells in a TNF-Driven Murine Model of Arthritis, J. Immunol, vol.186, pp.3899-3910, 2011.

J. Biton, S. Khaleghparast-athari, A. Thiolat, F. Santinon, D. Lemeiter et al., In Vivo Expansion of Activated Foxp3+ Regulatory T Cells and Establishment of a Type 2 Immune Response upon IL-33 Treatment Protect against Experimental Arthritis, J. Immunol. Baltim. Md, pp.1708-1719, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01933351

S. Blüml, N. B. Binder, B. Niederreiter, K. Polzer, S. Hayer et al., Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis, Arthritis Rheum, vol.62, pp.1608-1619, 2010.

X. Chen, M. Baumel, D. N. Mannel, O. M. Howard, and J. J. Oppenheim, Interaction of TNF with TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells, J. Immunol, vol.179, pp.154-161, 2007.

X. Chen, J. J. Subleski, H. Kopf, O. M. Howard, D. N. Mannel et al., Cutting Edge: Expression of TNFR2 Defines a Maximally Suppressive Subset of Mouse CD4+CD25+FoxP3+ T Regulatory Cells: Applicability to Tumor-Infiltrating T Regulatory Cells, J. Immunol, vol.180, pp.6467-6471, 2008.

X. Chen, J. J. Subleski, R. Hamano, O. M. Howard, R. H. Wiltrout et al., Co-expression of TNFR2 and CD25 identifies more of the functional CD4 + FOXP3 + regulatory T cells in human peripheral blood: Immunomodulation, Eur. J. Immunol, vol.40, pp.1099-1106, 2010.

X. Chen, X. Wu, Q. Zhou, O. M. Howard, M. G. Netea et al., , 2013.

, TNFR2 Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment, J. Immunol, vol.190, pp.1076-1084

X. Chen, Y. Nie, H. Xiao, Z. Bian, A. J. Scarzello et al., TNFR2 expression by CD4 effector T cells is required to induce full, 2016.

M. Chopra, M. Biehl, T. Steinfatt, A. Brandl, J. Kums et al., Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion, J. Exp. Med. jem, 2016.

Y. Deng, C. Chang, and Q. Lu, The Inflammatory Response in Psoriasis: a Comprehensive Review, Clin. Rev. Allergy Immunol, vol.50, pp.377-389, 2016.

A. I. D'hulst, K. R. Bracke, T. Maes, J. L. De-bleecker, R. A. Pauwels et al., Role of tumour necrosis factor-alpha receptor p75 in cigarette smokeinduced pulmonary inflammation and emphysema, Eur. Respir. J, vol.28, pp.102-112, 2006.

M. R. Ehrenstein, J. G. Evans, A. Singh, S. Moore, G. Warnes et al., Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNF? Therapy, J. Exp. Med, vol.200, pp.277-285, 2004.

R. Fischer, M. Proske, M. Duffey, H. Stangl, G. F. Martinez et al., Selective activation of tumor necrosis factor receptor 2 induces anti

B. Haraoui, L. Cameron, M. Ouellet, and B. White, Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response, J. Rheumatol, vol.33, pp.31-36, 2006.

G. C. Hildebrandt, K. M. Olkiewicz, L. Corrion, S. G. Clouthier, E. M. Pierce et al., A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome, Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant, vol.14, pp.385-396, 2008.

M. H. Holtmann, E. Douni, M. Schütz, G. Zeller, J. Mudter et al., Tumor necrosis factor-receptor 2 is upregulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo, Eur. J. Immunol, vol.32, pp.3142-3151, 2002.

X. Hu, B. Li, X. Li, X. Zhao, L. Wan et al., Transmembrane TNF-? Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2, J. Immunol, vol.192, pp.1320-1331, 2014.

C. O. Jacob and H. O. Mcdevitt, Tumour necrosis factor-alpha in murine autoimmune "lupus" nephritis, Nature, vol.331, pp.356-358, 1988.

G. D. Kalliolias and L. B. Ivashkiv, TNF biology, pathogenic mechanisms and emerging therapeutic strategies, Nat. Rev. Rheumatol, vol.12, 2015.

R. Keeton, N. Allie, I. Dambuza, B. Abel, N. Hsu et al., Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis, J. Clin. Invest, vol.124, pp.1537-1551, 2014.

E. Kemanetzoglou and E. Andreadou, CNS Demyelination with TNF-? Blockers, Curr. Neurol. Neurosci. Rep, vol.17, p.36, 2017.

A. Laurence, C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen et al., Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation, Immunity, vol.26, pp.371-381, 2007.

M. Leclerc, S. Naserian, C. Pilon, A. Thiolat, G. H. Martin et al., Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells, Blood, vol.128, pp.1651-1659, 2016.

X. Li, X. Chen, W. Gu, Y. Guo, Y. Cheng et al., Impaired TNF/TNFR2 signaling enhances Th2 and Th17 polarization and aggravates allergic airway inflammation, Am. J. Physiol.-Lung Cell. Mol. Physiol, vol.313, pp.592-601, 2017.

J. Liu, M. W. Marino, G. Wong, D. Grail, A. Dunn et al., TNF is a potent anti-inflammatory cytokine in autoimmunemediated demyelination, Nat. Med, vol.4, p.78, 1998.

L. Lu, J. Barbi, and F. Pan, The regulation of immune tolerance by FOXP3, Nat. Rev. Immunol, 2017.

P. M. Madsen, D. Motti, S. Karmally, D. E. Szymkowski, K. L. Lambertsen et al., Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination, J. Neurosci, vol.36, pp.5128-5143, 2016.

M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, vol.30, pp.899-911, 2009.

S. Nadkarni, C. Mauri, and M. R. Ehrenstein, Anti-TNF-? therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-?, J. Exp. Med, vol.204, pp.33-39, 2007.

D. X. Nguyen and M. R. Ehrenstein, Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis, J. Exp. Med, vol.213, pp.1241-1253, 2016.

E. Pfeifer, J. Polz, S. Grie?l, S. Mostböck, T. Hehlgans et al., Mechanisms of immune complex-mediated experimental glomerulonephritis: possible role of the balance between endogenous TNF and soluble TNF receptor type 2. Eur, Cytokine Netw, vol.23, pp.15-20, 2012.

J. K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe et al., DNA methylation controls Foxp3 gene expression, Eur. J. Immunol, vol.38, pp.1654-1663, 2008.

A. Rabinovitch, W. L. Suarez-pinzon, O. Sorensen, R. V. Rajotte, and R. F. Power, , 1997.

, TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice, J. Immunol, vol.159, pp.6298-6303

D. B. Rainbow, X. Yang, O. Burren, M. L. Pekalski, D. J. Smyth et al., Epigenetic analysis of regulatory T cells using multiplex bisulfite sequencing, Eur. J. Immunol, vol.45, pp.3200-3203, 2015.

J. A. Rickard, H. Anderton, N. Etemadi, U. Nachbur, M. Darding et al., TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice, vol.3, p.3464, 2014.

T. Schmid, L. Falter, S. Weber, N. Müller, K. Molitor et al., Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation, Front. Immunol, vol.8, 2017.

J. Sieper, D. Heijde, . Van-der, M. Dougados, P. J. Mease et al., Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1), Ann. Rheum. Dis, vol.72, pp.815-822, 2013.

B. Stoelcker, T. Hehlgans, K. Weigl, H. Bluethmann, G. E. Grau et al., Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria, Infect. Immun, vol.70, pp.5857-5859, 2002.

P. Suenaert, V. Bulteel, L. Lemmens, M. Noman, B. Geypens et al., Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease, Am. J. Gastroenterol, vol.97, 2000.

J. Tost and I. G. Gut, DNA methylation analysis by pyrosequencing, Nat. Protoc, vol.2, pp.2265-2275, 2007.

N. Tsakiri, D. Papadopoulos, M. C. Denis, D. Mitsikostas, and G. Kollias, TNFR2 on non-haematopoietic cells is required for Foxp3 + Treg-cell function and disease suppression in EAE: Immunomodulation, Eur. J. Immunol, vol.42, pp.403-412, 2012.

E. Zampeli, P. G. Vlachoyiannopoulos, and A. G. Tzioufas, Treatment of rheumatoid arthritis: Unraveling the conundrum, J. Autoimmun, vol.65, pp.1-18, 2015.

X. Zhao, L. Rong, X. Zhao, X. Li, X. Liu et al., TNF signaling drives myeloid-derived suppressor cell accumulation, J. Clin. Invest, vol.122, pp.4094-4104, 2012.

M. A. Abdallah, M. F. Abdel-hamid, A. M. Kotb, and E. A. Mabrouk, Serum interferongamma is a psoriasis severity and prognostic marker, Cutis, vol.84, pp.163-168, 2009.

F. J. Aceves-avila, S. Báez-molgado, F. Medina, and A. Fraga, Paleopathology in osseous remains from the 16th century. A survey of rheumatic diseases, J. Rheumatol, vol.25, pp.776-782, 1998.

B. B. Aggarwal, Signalling pathways of the TNF superfamily: a double-edged sword, Nat. Rev. Immunol, vol.3, pp.745-756, 2003.

L. Airas, J. Hellman, M. Salmi, P. Bono, T. Puurunen et al., CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocytevascular adhesion protein 2 identifies it as CD73, J. Exp. Med, vol.182, pp.1603-1608, 1995.

D. Aletaha, T. Neogi, A. J. Silman, J. Funovits, D. T. Felson et al., 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, vol.62, pp.2569-2581, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01557559

S. E. Allan, S. Q. Crome, N. K. Crellin, L. Passerini, T. S. Steiner et al., Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production, Int. Immunol, vol.19, pp.345-354, 2007.

W. Alwan and F. O. Nestle, Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine, Clin. Exp. Rheumatol, vol.33, pp.2-6, 2015.

F. Annunziato, L. Cosmi, F. Liotta, E. Lazzeri, R. Manetti et al., Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes, J. Exp. Med, vol.196, pp.379-387, 2002.

I. Apostolou, A. Sarukhan, L. Klein, and H. Boehmer, Origin of regulatory T cells with known specificity for antigen, Nat. Immunol, vol.3, pp.756-763, 2002.

W. P. Arend and G. S. Firestein, Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis, Nat. Rev. Rheumatol, vol.8, pp.573-586, 2012.

A. L. Astier, G. Meiffren, S. Freeman, and D. A. Hafler, Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis, J. Clin. Invest, vol.116, pp.3252-3257, 2006.
URL : https://hal.archives-ouvertes.fr/hal-02322380

S. M. Atkinson, P. A. Usher, P. H. Kvist, H. Markholst, C. Haase et al., , 2012.

, Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J mice, Arthritis Res. Ther, vol.14, p.134

S. M. Atkinson, U. Hoffmann, A. Hamann, E. Bach, N. B. Danneskiold-samsøe et al., Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade, Dis. Model. Mech, vol.9, pp.427-440, 2016.

A. Awasthi, Y. Carrier, J. P. Peron, E. Bettelli, M. Kamanaka et al., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells, Nat. Immunol, vol.8, pp.1380-1389, 2007.

E. Baecklund, C. Sundström, A. Ekbom, A. I. Catrina, P. Biberfeld et al., Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma, Arthritis Rheum, vol.48, pp.1543-1550, 2003.

F. J. Barrat, D. J. Cua, A. Boonstra, D. F. Richards, C. Crain et al., In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines, J. Exp. Med, vol.195, pp.603-616, 2002.

P. Barrera, . Th, A. M. Boerbooms, E. M. Janssen, R. W. Sauerwein et al., Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor ?, and interleukin-6 levels in rheumatoid arthritis, Arthritis Rheum, vol.36, pp.1070-1079, 1993.

R. Barthel, A. V. Tsytsykova, A. K. Barczak, E. Y. Tsai, C. C. Dascher et al., Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/p300, Mol. Cell. Biol, vol.23, pp.526-533, 2003.

C. L. Bennett, J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson et al., The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3, Nat. Genet, vol.27, pp.20-21, 2001.

M. J. Benson, K. Pino-lagos, M. Rosemblatt, N. , and R. J. , All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation, J. Exp. Med, vol.204, pp.1765-1774, 2007.

N. Bessis, P. Decker, E. Assier, L. Semerano, and M. Boissier, Arthritis models: usefulness and interpretation, Semin. Immunopathol, vol.39, pp.469-486, 2017.

E. Bettelli, Y. Carrier, W. Gao, T. Korn, T. B. Strom et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells, Nature, vol.441, pp.235-238, 2006.

K. R. Beutner and S. Tyring, Human papillomavirus and human disease, Am. J. Med, vol.102, pp.9-15, 1997.

R. A. Black, C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack et al., A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells, Nature, vol.385, pp.729-733, 1997.

F. J. Blanco, R. L. Ochs, H. Schwarz, and M. Lotz, Chondrocyte apoptosis induced by nitric oxide, Am. J. Pathol, vol.146, pp.75-85, 1995.

M. J. Bours, E. L. Swennen, F. Di-virgilio, B. N. Cronstein, and P. C. Dagnelie, , 2006.

, Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation, Pharmacol. Ther, vol.112, pp.358-404

P. F. Bradfield, N. Amft, E. Vernon-wilson, A. E. Exley, G. Parsonage et al., Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue, Arthritis Rheum, vol.48, pp.2472-2482, 2003.

D. Brenner, H. Blaser, and T. W. Mak, Regulation of tumour necrosis factor signalling: live or let die, Nat. Rev. Immunol, vol.15, pp.362-374, 2015.

B. Bresnihan, J. M. Alvaro-gracia, M. Cobby, M. Doherty, Z. Domljan et al., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, Arthritis Rheum, vol.41, pp.2196-2204, 1998.

B. M. Brinkman, J. B. Telliez, A. R. Schievella, L. L. Lin, and A. E. Goldfeld, Engagement of tumor necrosis factor (TNF) receptor 1 leads to ATF-2-and p38 mitogen-activated protein kinase-dependent TNF-alpha gene expression, J. Biol. Chem, vol.274, pp.30882-30886, 1999.

M. E. Brunkow, E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark et al., Disruption of a new forkhead/wingedhelix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse, Nat. Genet, vol.27, pp.68-73, 2001.

M. H. Buch, D. L. Boyle, S. Rosengren, B. Saleem, R. J. Reece et al., Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study, Ann. Rheum. Dis, vol.68, pp.1220-1227, 2009.

M. H. Buch, J. S. Smolen, N. Betteridge, F. C. Breedveld, G. Burmester et al., Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis, Ann. Rheum. Dis, vol.70, pp.909-920, 2011.

M. A. Burchill, J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar, IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells, J. Immunol. Baltim. Md, vol.178, pp.280-290, 1950.

M. A. Burchill, J. Yang, K. B. Vang, J. J. Moon, H. H. Chu et al., Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire, Immunity, vol.28, pp.112-121, 2008.

G. R. Burmester, X. Mariette, C. Montecucco, I. Monteagudo-sáez, M. Malaise et al., Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial, Ann. Rheum. Dis, vol.66, pp.732-739, 2007.

Z. Cai, S. Jitkaew, J. Zhao, H. Chiang, S. Choksi et al., Plasma membrane translocation of trimerized MLKL protein is required for TNFinduced necroptosis, Nat. Cell Biol, vol.16, pp.55-65, 2014.

S. Capellino, M. Cosentino, C. Wolff, M. Schmidt, J. Grifka et al., , 2010.

, Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target, Ann. Rheum. Dis, vol.69, pp.1853-1860

J. D. Carter, G. M. Calabrese, M. Naganuma, and U. Lorenz, Deficiency of the Src homology region 2 domain-containing phosphatase 1 (SHP-1) causes enrichment of CD4+CD25+ regulatory T cells, J. Immunol. Baltim. Md, vol.174, pp.6627-6638, 1950.

R. Cascão, H. S. Rosário, M. M. Souto-carneiro, and J. E. Fonseca, Neutrophils in rheumatoid arthritis: More than simple final effectors, Autoimmun. Rev, vol.9, pp.531-535, 2010.

J. P. Case, Old and new drugs used in rheumatoid arthritis: a historical perspective. Part 1: the older drugs, Am. J. Ther, vol.8, pp.123-143, 2001.

M. Chabaud, F. Fossiez, J. L. Taupin, and P. Miossec, Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines, J. Immunol. Baltim. Md, vol.161, pp.409-414, 1950.

K. A. Charles, H. Kulbe, R. Soper, M. Escorcio-correia, T. Lawrence et al., The tumor-promoting actions of TNF-? involve TNFR1 and IL-17 in ovarian cancer in mice and humans, J. Clin. Invest, vol.119, pp.3011-3023, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00499385

A. Chaudhry, D. Rudra, P. Treuting, R. M. Samstein, Y. Liang et al., CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner, vol.326, pp.986-991, 2009.

J. Chen, K. Wright, J. M. Davis, P. Jeraldo, E. V. Marietta et al., An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis, Genome Med, vol.8, p.43, 2016.

X. Chen, X. Wu, Q. Zhou, O. M. Howard, M. G. Netea et al., , p.2, 2013.

, Is Critical for the Stabilization of the CD4+Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment, J. Immunol, vol.190, pp.1076-1084

X. Chen, Y. Nie, H. Xiao, Z. Bian, A. J. Scarzello et al., TNFR2 expression by CD4 effector T cells is required to induce full, 2016.

C. Chizzolini, R. Chicheportiche, M. Alvarez, C. De-rham, P. Roux-lombard et al., Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion, Blood, vol.112, pp.3696-3703, 2008.

J. W. Choi, D. G. Kim, M. C. Park, J. Y. Um, J. M. Han et al., AIMP2 promotes TNFalpha-dependent apoptosis via ubiquitin-mediated degradation of TRAF2, J. Cell Sci, vol.122, pp.2710-2715, 2009.

M. Chopra, M. Biehl, T. Steinfatt, A. Brandl, J. Kums et al., Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion, J. Exp. Med. jem, 2016.

N. Chunder, L. Wang, C. Chen, W. W. Hancock, and A. D. Wells, Cyclin-dependent kinase 2 controls peripheral immune tolerance, J. Immunol. Baltim. Md, vol.189, pp.5659-5666, 1950.

Y. Chung, S. Tanaka, F. Chu, R. I. Nurieva, G. J. Martinez et al., Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions, Nat. Med, vol.17, pp.983-988, 2011.

R. De-cid, E. Riveira-munoz, P. L. Zeeuwen, J. Robarge, W. Liao et al., Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis, Nat. Genet, vol.41, pp.211-215, 2009.

I. M. Clark, L. K. Powell, S. Ramsey, B. L. Hazleman, and T. E. Cawston, The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis, Arthritis Rheum, vol.36, pp.372-379, 1993.

S. P. Cobbold, E. Adams, C. A. Farquhar, K. F. Nolan, D. Howie et al., Infectious tolerance via the consumption of essential amino acids and mTOR signaling, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.12055-12060, 2009.

J. L. Coombes, K. R. Siddiqui, C. V. Arancibia-cárcamo, J. Hall, C. Sun et al., A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism, J. Exp. Med, vol.204, pp.1757-1764, 2007.

R. C. Cornell and R. B. Stoughton, Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis, Br. J. Dermatol, vol.105, pp.91-95, 1981.

J. C. Cronk, N. C. Derecki, E. Ji, Y. Xu, A. E. Lampano et al., Methyl-CpG Binding Protein 2 Regulates Microglia and Macrophage Gene Expression in Response to Inflammatory Stimuli, Immunity, vol.42, pp.679-691, 2015.

E. V. Dang, J. Barbi, H. Yang, D. Jinasena, H. Yu et al., Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1, vol.146, pp.772-784, 2011.

S. Deaglio, K. M. Dwyer, W. Gao, D. Friedman, A. Usheva et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression, J. Exp. Med, vol.204, pp.1257-1265, 2007.

G. Deng, Y. Nagai, Y. Xiao, Z. Li, S. Dai et al., Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation, J. Biol. Chem, vol.290, pp.20211-20220, 2015.

Y. Deng, C. Chang, and Q. Lu, The Inflammatory Response in Psoriasis: a Comprehensive Review, Clin. Rev. Allergy Immunol, vol.50, pp.377-389, 2016.

D. Diarra, M. Stolina, K. Polzer, J. Zwerina, M. S. Ominsky et al., Dickkopf-1 is a master regulator of joint remodeling, Nat. Med, vol.13, pp.156-163, 2007.

P. Dieudé, E. Petit, S. Cailleau-moindrault, J. Osorio, C. Pierlot et al., Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: evidence for genetic heterogeneity, Arthritis Rheum, vol.46, pp.2039-2044, 2002.

A. A. Drosos, L. Christou, V. Galanopoulou, A. G. Tzioufas, and E. K. Tsiakou, Dpenicillamine induced myasthenia gravis: clinical, serological and genetic findings, Clin. Exp. Rheumatol, vol.11, pp.387-391, 1993.

A. A. Drosos, N. Tsifetaki, E. K. Tsiakou, M. Timpanidou, C. Tsampoulas et al., Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study, Clin. Exp. Rheumatol, vol.15, pp.263-267, 1997.

C. Du, M. Fang, Y. Li, L. Li, W. et al., Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition, Cell, vol.102, pp.33-42, 2000.

S. Dutta, A. , and Y. , The efficacy and safety of tacrolimus in rheumatoid arthritis, Ther. Adv. Musculoskelet. Dis, vol.3, pp.283-291, 2011.

J. C. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-sosnowska, P. Emery et al., Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis, N. Engl. J. Med, vol.350, pp.2572-2581, 2004.

J. T. Elder, PSORS1: linking genetics and immunology, J. Invest. Dermatol, vol.126, pp.1205-1206, 2006.

W. Elyaman, E. M. Bradshaw, C. Uyttenhove, V. Dardalhon, A. Awasthi et al., IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.12885-12890, 2009.

P. Emery, R. Fleischmann, A. Filipowicz-sosnowska, J. Schechtman, L. Szczepanski et al., The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebocontrolled, dose-ranging trial, Arthritis Rheum, vol.54, pp.1390-1400, 2006.

. Encode-project-consortium, E. Birney, J. A. Stamatoyannopoulos, A. Dutta, R. Guigó et al., Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Nature, vol.447, pp.799-816, 2007.

K. Enesa, M. Zakkar, H. Chaudhury, L. A. Luong, L. Rawlinson et al., NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling, J. Biol. Chem, vol.283, pp.7036-7045, 2008.

E. Espel, The role of the AU-rich elements of mRNAs in controlling translation, Semin. Cell Dev. Biol, vol.16, pp.59-67, 2005.

H. Eugster, K. Frei, R. Bachmann, H. Bluethmann, H. Lassmann et al., Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1, Eur. J. Immunol, vol.29, pp.626-632, 1999.

D. L. Faustman, TNF, TNF inducers, and TNFR2 agonists: A new path to type 1 diabetes treatment, Diabetes Metab. Res. Rev, 2017.

Y. Feng, J. Van-der-veeken, M. Shugay, E. V. Putintseva, H. U. Osmanbeyoglu et al., A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance, Nature, vol.528, pp.132-136, 2015.

A. Filer, G. Parsonage, E. Smith, C. Osborne, A. M. Thomas et al., Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils, Arthritis Rheum, vol.54, pp.2096-2108, 2006.

R. Fischer, M. Proske, M. Duffey, H. Stangl, G. F. Martinez et al., Selective activation of tumor necrosis factor receptor 2 induces anti

L. Van-der-fits, S. Mourits, J. S. Voerman, M. Kant, L. Boon et al., Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis, J. Immunol. Baltim. Md, vol.182, pp.5836-5845, 1950.

J. D. Fontenot, J. P. Rasmussen, M. A. Gavin, and A. Y. Rudensky, A function for interleukin 2 in Foxp3-expressing regulatory T cells, Nat. Immunol, vol.6, pp.1142-1151, 2005.

J. Forestier, RHEUMATOID ARTHRITIS AND ITS TREATMENT BY GOLD SALTS, The Lancet, vol.224, pp.646-648, 1934.

M. Fotin-mleczek, F. Henkler, D. Samel, M. Reichwein, A. Hausser et al., Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8, J. Cell Sci, vol.115, pp.2757-2770, 2002.

H. Fukaura, S. C. Kent, M. J. Pietrusewicz, S. J. Khoury, H. L. Weiner et al., Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients, J. Clin. Invest, vol.98, pp.70-77, 1996.

Y. Furusawa, Y. Obata, S. Fukuda, T. A. Endo, G. Nakato et al., Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells, Nature, vol.504, pp.446-450, 2013.

N. Gagliani, T. Jofra, A. Stabilini, A. Valle, M. Atkinson et al.,

, Antigen-specific dependence of Tr1-cell therapy in preclinical models of islet transplant, Diabetes, vol.59, pp.433-439

T. Geiler, J. Kriegsmann, G. M. Keyszer, R. E. Gay, and S. Gay, A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice, Arthritis Rheum, vol.37, pp.1664-1671, 1994.

A. Strange, F. Capon, C. C. Spencer, J. Knight, M. E. Weale et al., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1, Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2, vol.42, pp.985-990, 2010.

M. C. Genovese, . Van-den, F. Bosch, S. A. Roberson, S. Bojin et al., LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study, Arthritis Rheum, vol.62, pp.929-939, 2010.

R. K. Gershon and K. Kondo, Cell interactions in the induction of tolerance: the role of thymic lymphocytes, Immunology, vol.18, pp.723-737, 1970.

K. E. Gilbert, I. F. Manalo, and J. J. Wu, Efficacy and safety of etanercept and adalimumab with and without a loading dose for psoriasis: A systematic review, J. Am. Acad. Dermatol, vol.73, pp.329-331, 2015.

A. E. Goldfeld, P. G. Mccaffrey, J. L. Strominger, and A. Rao, Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter, J. Exp. Med, vol.178, pp.1365-1379, 1993.

D. C. Gondek, L. Lu, S. A. Quezada, S. Sakaguchi, N. et al., Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme Bdependent, perforin-independent mechanism, J. Immunol. Baltim. Md, vol.174, pp.1783-1786, 1950.

J. E. Gottenberg, P. Ravaud, A. Cantagrel, B. Combe, R. M. Flipo et al., Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the "Orencia and Rheumatoid Arthritis" registry, Ann. Rheum. Dis, vol.71, pp.1815-1819, 2012.

C. Govindaraj, K. Scalzo-inguanti, M. Madondo, J. Hallo, K. Flanagan et al., Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment, Clin. Immunol, vol.149, pp.97-110, 2013.

C. Govindaraj, P. Tan, P. Walker, A. Wei, A. Spencer et al., Reducing TNF receptor 2+ regulatory T cells via the combined action of azacitidine and the HDAC inhibitor, panobinostat for clinical benefit in acute myeloid leukemia patients, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.20, pp.724-735, 2014.

J. R. Grainger, K. A. Smith, J. P. Hewitson, H. J. Mcsorley, Y. Harcus et al., Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-? pathway, J. Exp. Med, vol.207, pp.2331-2341, 2010.

E. M. Gravallese, Y. Harada, J. T. Wang, A. H. Gorn, T. S. Thornhill et al., Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis, Am. J. Pathol, vol.152, pp.943-951, 1998.

P. K. Gregersen, J. Silver, and R. J. Winchester, The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis Rheum, vol.30, pp.1205-1213, 1987.

W. J. Grossman, J. W. Verbsky, W. Barchet, M. Colonna, J. P. Atkinson et al., , 2004.

, Human T regulatory cells can use the perforin pathway to cause autologous target cell death, Immunity, vol.21, pp.589-601

H. Groux, A. O'garra, M. Bigler, M. Rouleau, S. Antonenko et al., A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, vol.389, pp.737-742, 1997.

R. Gubner, S. August, and V. Ginsberg, Therapeutic suppression of tissue reactivity, 1951.

, Effect of aminopterin in rheumatoid arthritis and psoriasis, Am. J. Med. Sci, vol.221, pp.176-182

T. L. Haas, C. H. Emmerich, B. Gerlach, A. C. Schmukle, S. M. Cordier et al., Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction, Mol. Cell, vol.36, pp.831-844, 2009.

R. Hamano, J. Huang, T. Yoshimura, J. J. Oppenheim, C. et al., TNF optimally activatives regulatory T cells by inducing TNF receptor superfamily members TNFR2, 4-1BB and OX40, Eur. J. Immunol, vol.41, 2010.

D. C. Hargreaves, T. Horng, and R. Medzhitov, Control of inducible gene expression by signal-dependent transcriptional elongation, Cell, vol.138, pp.129-145, 2009.

J. J. Haringman, D. M. Gerlag, A. H. Zwinderman, T. J. Smeets, M. C. Kraan et al., Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis, Ann. Rheum. Dis, vol.64, pp.834-838, 2005.

U. Harre, D. Georgess, H. Bang, A. Bozec, R. Axmann et al., Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin, J. Clin. Invest, vol.122, pp.1791-1802, 2012.

-. Hartigan, D. J. Connor, C. Poon, E. Sinclair, and J. M. Mccune, Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells, J. Immunol. Methods, vol.319, pp.41-52, 2007.

J. Hauer, S. Püschner, P. Ramakrishnan, U. Simon, M. Bongers et al., TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.2874-2879, 2005.

D. M. Van-der-heijde, Joint erosions and patients with early rheumatoid arthritis, Br. J. Rheumatol, vol.34, issue.2, pp.74-78, 1995.

A. Hess, R. Axmann, J. Rech, S. Finzel, C. Heindl et al., Blockade of TNF-? rapidly inhibits pain responses in the central nervous system, Proc. Natl. Acad. Sci. U. S. A, vol.108, pp.3731-3736, 2011.

M. L. Hetland, B. Ejbjerg, K. Hørslev-petersen, S. Jacobsen, A. Vestergaard et al., MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA), Ann. Rheum. Dis, vol.68, pp.384-390, 2009.

V. M. Heydendael, P. I. Spuls, B. C. Opmeer, C. A. De-borgie, J. B. Reitsma et al., Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis, N. Engl. J. Med, vol.349, pp.658-665, 2003.

J. N. Hoes, J. W. Jacobs, M. Boers, D. Boumpas, F. Buttgereit et al., EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases, Ann. Rheum. Dis, vol.66, pp.1560-1567, 2007.

T. Höfer, O. Krichevsky, and G. Bonnet, Competition for IL-2 between Regulatory and Effector T Cells to Chisel Immune Responses, Front. Immunol, vol.3, p.268, 2012.

S. Hori, T. Nomura, and S. Sakaguchi, Control of regulatory T cell development by the transcription factor Foxp3, Science, vol.299, pp.1057-1061, 2003.

D. A. Horwitz, S. G. Zheng, J. Wang, and J. D. Gray, Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg, Eur. J. Immunol, vol.38, pp.912-915, 2008.

M. Hou, S. Huang, M. Tsai, C. Yen, Y. Lai et al., The interleukin-15 system suppresses T cell-mediated autoimmunity by regulating negative selection and nT(H)17 cell homeostasis in the thymus, J. Autoimmun, vol.56, pp.118-129, 2015.

C. Hsieh, Y. Liang, A. J. Tyznik, S. G. Self, D. Liggitt et al., Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors, Immunity, vol.21, pp.267-277, 2004.

C. Hsieh, Y. Zheng, Y. Liang, J. D. Fontenot, and A. Y. Rudensky, An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires, Nat. Immunol, vol.7, pp.401-410, 2006.

H. Hsu, J. Xiong, and D. V. Goeddel, The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation, Cell, vol.81, pp.495-504, 1995.

X. Hu, B. Li, X. Li, X. Zhao, L. Wan et al., , 2014.

T. Transmembrane, Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2, J. Immunol, vol.192, pp.1320-1331

O. Hultgren, H. Eugster, J. D. Sedgwick, H. Körner, and A. Tarkowski, , 1998.

, TNF/Lymphotoxin-? Double-Mutant Mice Resist Septic Arthritis but Display Increased Mortality in Response to Staphylococcus aureus, J. Immunol, vol.161, pp.5937-5942

C. Iobagiu, A. Magyar, L. Nogueira, M. Cornillet, M. Sebbag et al., The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted, J. Autoimmun, vol.37, pp.263-272, 2011.

M. W. Irwin, S. Mak, D. L. Mann, R. Qu, J. M. Penninger et al., Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium, Circulation, vol.99, pp.1492-1498, 1999.

J. D. Isaacs, S. B. Cohen, P. Emery, P. P. Tak, J. Wang et al., Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis, Ann. Rheum. Dis, vol.72, pp.329-336, 2013.

A. Israël, The IKK complex, a central regulator of NF-kappaB activation, Cold Spring Harb. Perspect. Biol, vol.2, p.158, 2010.

T. Ito, S. Hanabuchi, Y. Wang, W. R. Park, K. Arima et al., Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery, Immunity, vol.28, pp.870-880, 2008.

I. I. Ivanov, B. S. Mckenzie, L. Zhou, C. E. Tadokoro, A. Lepelley et al., The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells, Cell, vol.126, pp.1121-1133, 2006.

L. T. Jacobsson, C. Turesson, A. Gülfe, M. C. Kapetanovic, I. F. Petersson et al., Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis, J. Rheumatol, vol.32, pp.1213-1218, 2005.

C. Johansen, P. A. Usher, R. B. Kjellerup, D. Lundsgaard, L. Iversen et al., Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin, Br. J. Dermatol, vol.160, pp.319-324, 2009.

L. M. Johnson-huang, M. Suárez-fariñas, K. C. Pierson, J. Fuentes-duculan, I. Cueto et al., A single intradermal injection of IFN-? induces an inflammatory state in both non-lesional psoriatic and healthy skin, J. Invest. Dermatol, vol.132, pp.1177-1187, 2012.

A. Johnston, J. E. Gudjonsson, H. Sigmundsdottir, T. J. Love, and H. Valdimarsson, Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells, Clin. Exp. Immunol, vol.138, pp.83-93, 2004.

S. Z. Josefowicz, C. B. Wilson, and A. Y. Rudensky, Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1, J. Immunol. Baltim. Md, vol.182, pp.6648-6652, 1950.

S. Z. Josefowicz, R. E. Niec, H. Y. Kim, P. Treuting, T. Chinen et al., Extrathymically generated regulatory T cells control mucosal TH2 inflammation, Nature, vol.482, pp.395-399, 2012.

G. D. Kalliolias and L. B. Ivashkiv, TNF biology, pathogenic mechanisms and emerging therapeutic strategies, Nat. Rev. Rheumatol, vol.12, 2015.

S. Kamphuis, W. Kuis, W. De-jager, G. Teklenburg, M. Massa et al., Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis, Lancet Lond. Engl, vol.366, pp.50-56, 2005.

J. Keffer, L. Probert, H. Cazlaris, S. Georgopoulos, E. Kaslaris et al., Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J, vol.10, pp.4025-4031, 1991.

J. Von-kempis, J. Dudler, P. Hasler, D. Kyburz, A. Tyndall et al., Use of abatacept in rheumatoid arthritis, Swiss Med. Wkly, vol.142, p.13581, 2012.

L. E. Kilpatrick, S. Sun, D. Mackie, F. Baik, H. Li et al., Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2, J. Leukoc. Biol, vol.80, pp.1512-1521, 2006.

E. Y. Kim, J. J. Priatel, S. Teh, and H. Teh, TNF Receptor Type 2 (p75) Functions as a Costimulator for Antigen-Driven T Cell Responses In Vivo, J. Immunol, vol.176, pp.1026-1035, 2006.

M. A. Koch, G. Tucker-heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl et al., The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation, Nat. Immunol, vol.10, pp.595-602, 2009.

S. Kochanek, M. Toth, A. Dehmel, D. Renz, and W. Doerfler, Interindividual concordance of methylation profiles in human genes for tumor necrosis factors alpha and beta, Proc. Natl. Acad. Sci. U. S. A, vol.87, pp.8830-8834, 1990.

S. Kochanek, A. Radbruch, H. Tesch, D. Renz, and W. Doerfler, DNA methylation profiles in the human genes for tumor necrosis factors alpha and beta in subpopulations of leukocytes and in leukemias, Proc. Natl. Acad. Sci. U. S. A, vol.88, pp.5759-5763, 1991.

V. Kouskoff, A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist et al., Organ-specific disease provoked by systemic autoimmunity, Cell, vol.87, pp.811-822, 1996.

J. M. Kremer, B. J. Bloom, F. C. Breedveld, J. H. Coombs, M. P. Fletcher et al., The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo, Arthritis Rheum, vol.60, pp.1895-1905, 2009.

K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig et al., Inducing and expanding regulatory T cell populations by foreign antigen, Nat. Immunol, vol.6, pp.1219-1227, 2005.

M. Kriegler, C. Perez, K. Defay, I. Albert, and S. D. Lu, A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF, Cell, vol.53, pp.45-53, 1988.

I. Kryczek, A. T. Bruce, J. E. Gudjonsson, A. Johnston, A. Aphale et al., Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis, J. Immunol. Baltim. Md, vol.181, pp.4733-4741, 1950.

I. Kryczek, R. Liu, G. Wang, K. Wu, X. Shu et al., FOXP3 defines regulatory T cells in human tumor and autoimmune disease, Cancer Res, vol.69, pp.3995-4000, 2009.

Y. Lai, D. Li, C. Li, B. Muehleisen, K. A. Radek et al., The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury, Immunity, vol.37, pp.74-84, 2012.

J. Lam, S. Takeshita, J. E. Barker, O. Kanagawa, F. P. Ross et al., TNFalpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand, J. Clin. Invest, vol.106, pp.1481-1488, 2000.

V. Lamontain, T. Schmid, D. Weber-steffens, D. Zeller, Z. Jenei-lanzl et al., Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice, Cell. Mol. Immunol, 2018.

S. K. Lathrop, S. M. Bloom, S. M. Rao, K. Nutsch, C. Lio et al., Peripheral education of the immune system by colonic commensal microbiota, Nature, vol.478, pp.250-254, 2011.

A. Laurence, C. M. Tato, T. S. Davidson, Y. Kanno, Z. Chen et al., Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation, Immunity, vol.26, pp.371-381, 2007.

A. Laurence, S. Amarnath, J. Mariotti, Y. C. Kim, J. Foley et al., STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease, Immunity, vol.37, pp.209-222, 2012.

A. Lee, Y. Qiao, G. Grigoriev, J. Chen, K. Park-min et al., Tumor necrosis factor ? induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts, Arthritis Rheum, vol.65, pp.928-938, 2013.

D. M. Lee, H. P. Kiener, S. K. Agarwal, E. H. Noss, G. F. Watts et al., Cadherin-11 in synovial lining formation and pathology in arthritis, Science, vol.315, pp.1006-1010, 2007.

S. Lefèvre, A. Knedla, C. Tennie, A. Kampmann, C. Wunrau et al., Synovial fibroblasts spread rheumatoid arthritis to unaffected joints, Nat. Med, vol.15, pp.1414-1420, 2009.

D. F. Legler, O. Micheau, M. Doucey, J. Tschopp, and C. Bron, Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation, Immunity, vol.18, pp.655-664, 2003.

J. Li, T. Mcquade, A. B. Siemer, J. Napetschnig, K. Moriwaki et al., The RIP1/RIP3 necrosome forms a functional amyloid signaling complex required for programmed necrosis, Cell, vol.150, pp.339-350, 2012.

Z. Li, F. Lin, C. Zhuo, G. Deng, Z. Chen et al., PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation, J. Biol. Chem, vol.289, pp.26872-26881, 2014.

G. Liao, C. Detre, S. B. Berger, P. Engel, R. De-waal-malefyt et al., Glucocorticoid-induced tumor necrosis factor receptor family-related protein regulates CD4(+)T cell-mediated colitis in mice, Gastroenterology, vol.142, pp.582-591, 2012.

C. J. Lio and C. Hsieh, A two-step process for thymic regulatory T cell development, Immunity, vol.28, pp.100-111, 2008.

C. B. Little, A. Barai, D. Burkhardt, S. M. Smith, A. J. Fosang et al., Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development, Arthritis Rheum, vol.60, pp.3723-3733, 2009.

W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee et al., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells, J. Exp. Med, vol.203, pp.1701-1711, 2006.

Y. Liu, P. Zhang, J. Li, A. B. Kulkarni, S. Perruche et al., A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells, Nat. Immunol, vol.9, pp.632-640, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00484154

Y. Liu, C. Helms, W. Liao, L. C. Zaba, S. Duan et al., A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci, PLoS Genet, vol.4, p.1000041, 2008.

P. F. Lizzul, A. Aphale, R. Malaviya, Y. Sun, S. Masud et al., Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept, J. Invest. Dermatol, vol.124, pp.1275-1283, 2005.

J. Van-loosdregt, Y. Vercoulen, T. Guichelaar, Y. Y. Gent, J. M. Beekman et al., Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization, Blood, vol.115, pp.965-974, 2010.

J. Van-loosdregt, V. Fleskens, J. Fu, A. B. Brenkman, C. P. Bekker et al., Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity, Immunity, vol.39, pp.259-271, 2013.

L. Lu, J. Barbi, and F. Pan, The regulation of immune tolerance by FOXP3, Nat. Rev. Immunol, 2017.

A. D. Luster, R. Alon, U. H. Andrian, and . Von, Immune cell migration in inflammation: present and future therapeutic targets, Nat. Immunol, vol.6, p.1182, 2005.

A. J. Macgregor, H. Snieder, A. S. Rigby, M. Koskenvuo, J. Kaprio et al., Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins, Arthritis Rheum, vol.43, pp.30-37, 2000.

H. Mahdi, B. A. Fisher, H. Källberg, D. Plant, V. Malmström et al., Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis, Nat. Genet, vol.41, pp.1319-1324, 2009.

S. Malchow, D. S. Leventhal, V. Lee, S. Nishi, N. D. Socci et al., Aire Enforces Immune Tolerance by Directing Autoreactive T Cells into the Regulatory T Cell Lineage, Immunity, vol.44, pp.1102-1113, 2016.

P. Mantel, N. Ouaked, B. Rückert, C. Karagiannidis, R. Welz et al., Molecular mechanisms underlying FOXP3 induction in human T cells, J. Immunol. Baltim. Md, vol.176, pp.3593-3602, 1950.

L. Marinova-mutafchieva, C. Gabay, K. Funa, and R. O. Williams, Remission of collagen-induced arthritis is associated with high levels of transforming growth factor-? expression in the joint, Clin. Exp. Immunol, vol.146, pp.287-293, 2006.

B. Marston, A. Palanichamy, and J. H. Anolik, B cells in the pathogenesis and treatment of rheumatoid arthritis, Curr. Opin. Rheumatol, vol.22, pp.307-315, 2010.

E. M. Martin, A. Remke, E. Pfeifer, J. Polz, A. Pietryga-krieger et al., TNFR2 maintains adequate IL-12 production by dendritic cells in inflammatory responses by regulating endogenous TNF levels, Innate Immun, vol.20, pp.712-720, 2014.

S. Matsuda and S. Koyasu, Mechanisms of action of cyclosporine, Immunopharmacology, vol.47, pp.119-125, 2000.

C. Mauri, R. O. Williams, M. Walmsley, and M. Feldmann, Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis, Eur. J. Immunol, vol.26, pp.1511-1518, 1996.

D. Mcgonagle, A. L. Tan, U. Møller-døhn, M. Ostergaard, and M. Benjamin, , 2009.

, Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis, Arthritis Rheum, vol.60, pp.1042-1051

J. L. Mcgovern, D. X. Nguyen, C. A. Notley, C. Mauri, D. A. Isenberg et al., Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy, Arthritis Rheum, vol.64, pp.3129-3138, 2012.

I. B. Mcinnes and G. Schett, The Pathogenesis of Rheumatoid Arthritis, N. Engl. J. Med, vol.365, pp.2205-2219, 2011.

F. Miao, I. G. Gonzalo, L. Lanting, and R. Natarajan, In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions, J. Biol. Chem, vol.279, pp.18091-18097, 2004.

O. Micheau and J. Tschopp, Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes, Cell, vol.114, pp.181-190, 2003.
URL : https://hal.archives-ouvertes.fr/inserm-00527105

T. Mijatovic, L. Houzet, P. Defrance, L. Droogmans, G. Huez et al., Tumor necrosis factor-alpha mRNA remains unstable and hypoadenylated upon stimulation of macrophages by lipopolysaccharides, Eur. J. Biochem, vol.267, pp.6004-6012, 2000.

P. G. Miller, M. B. Bonn, and S. C. Mckarns, Transmembrane TNF-TNFR2 Impairs Th17 Differentiation by Promoting Il2 Expression, J. Immunol. Baltim. Md, pp.2633-2647, 2015.

G. Minigo, T. Woodberry, K. A. Piera, E. Salwati, E. Tjitra et al., Parasite-Dependent Expansion of TNF Receptor II-Positive Regulatory T Cells with Enhanced Suppressive Activity in Adults with Severe Malaria, PLoS Pathog, vol.5, 2009.

R. Mohamud, J. S. Lemasurier, J. C. Boer, J. L. Sieow, J. M. Rolland et al., Synthetic Nanoparticles That Promote Tumor Necrosis Factor Receptor 2 Expressing Regulatory T Cells in the Lung and Resistance to Allergic Airways Inflammation, 2017.

D. Mougiakakos, C. C. Johansson, R. Jitschin, M. Böttcher, and R. Kiessling, Increased thioredoxin-1 production in human naturally occurring regulatory T cells confers enhanced tolerance to oxidative stress, Blood, vol.117, pp.857-861, 2011.

S. Muller and M. Radic, Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms, Clin. Rev. Allergy Immunol, vol.49, pp.232-239, 2015.

R. Munker, J. Gasson, M. Ogawa, and H. P. Koeffler, Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor, Nature, vol.323, pp.79-82, 1986.

J. M. Murphy, P. E. Czabotar, J. M. Hildebrand, I. S. Lucet, J. Zhang et al., The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism, Immunity, vol.39, pp.443-453, 2013.

S. Nadkarni, C. Mauri, and M. R. Ehrenstein, Anti-TNF-? therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-?, J. Exp. Med, vol.204, pp.33-39, 2007.

R. P. Nair, K. C. Duffin, C. Helms, J. Ding, P. E. Stuart et al., Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways, Nat. Genet, vol.41, pp.199-204, 2009.

V. S. Nair, M. H. Song, M. Ko, and K. I. Oh, DNA Demethylation of the Foxp3 Enhancer Is Maintained through Modulation of Ten-Eleven-Translocation and DNA Methyltransferases, Mol. Cells, vol.39, pp.888-897, 2016.

S. Nakae, S. Saijo, R. Horai, K. Sudo, S. Mori et al., IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.5986-5990, 2003.

K. Nakano, D. L. Boyle, and G. S. Firestein, Regulation of DNA methylation in rheumatoid arthritis synoviocytes, J. Immunol. Baltim. Md, pp.1297-1303, 2013.

H. Nie, Y. Zheng, R. Li, T. B. Guo, D. He et al., Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF? in rheumatoid arthritis, Nat. Med, vol.19, pp.322-328, 2013.

K. Nozawa, M. Fujishiro, Y. Takasaki, and I. Sekigawa, Inhibition of rheumatoid arthritis by blocking connective tissue growth factor, World J. Orthop, vol.5, pp.653-659, 2014.

Y. Okubo, T. Mera, L. Wang, and D. L. Faustman, Homogeneous Expansion of Human T-Regulatory Cells Via Tumor Necrosis Factor Receptor 2, 2013.

C. Ottaviani, F. Nasorri, C. Bedini, O. De-pità, G. Girolomoni et al., , 2006.

. Cd56brightcd16, NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation, Eur. J. Immunol, vol.36, pp.118-128

W. Ouyang, O. Beckett, Q. Ma, J. Paik, R. A. Depinho et al., Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells, Nat. Immunol, vol.11, pp.618-627, 2010.

R. Pacholczyk, H. Ignatowicz, P. Kraj, and L. Ignatowicz, Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells, Immunity, vol.25, pp.249-259, 2006.

J. Park, S. Wacholder, M. H. Gail, U. Peters, K. B. Jacobs et al., Estimation of effect size distribution from genome-wide association studies and implications for future discoveries, Nat. Genet, vol.42, pp.570-575, 2010.

S. H. Park, K. Park-min, J. Chen, X. Hu, and L. B. Ivashkiv, Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages, Nat. Immunol, vol.12, pp.607-615, 2011.

C. Pasare and R. Medzhitov, Toll pathway-dependent blockade of CD4+CD25+ T cellmediated suppression by dendritic cells, Science, vol.299, pp.1033-1036, 2003.

E. J. Pearce, P. Caspar, J. Grzych, F. A. Lewis, and A. Sher, Pillars Article: Downregulation of Th1 Cytokine Production Accompanies Induction of Th2 Responses by a Parasitic Helminth, Schistosoma mansoni, J. Exp. Med, vol.173, pp.1104-1111, 1991.

M. J. Peters, D. P. Symmons, D. Mccarey, B. A. Dijkmans, P. Nicola et al., EULAR evidencebased recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis, Ann. Rheum. Dis, vol.69, pp.325-331, 2010.

R. M. Plenge, C. Cotsapas, L. Davies, A. L. Price, P. I. De-bakker et al., Two independent alleles at 6q23 associated with risk of rheumatoid arthritis, Nat. Genet, vol.39, pp.1477-1482, 2007.

J. K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe et al., DNA methylation controls Foxp3 gene expression, Eur. J. Immunol, vol.38, pp.1654-1663, 2008.

K. Polzer, D. Baeten, A. Soleiman, J. Distler, D. M. Gerlag et al., Tumour necrosis factor blockade increases lymphangiogenesis in murine and human arthritic joints, Ann. Rheum. Dis, vol.67, pp.1610-1616, 2008.

F. Powrie and D. Mason, OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset, J. Exp. Med, vol.172, pp.1701-1708, 1990.

S. Punit, P. E. Dubé, C. Y. Liu, N. Girish, M. K. Washington et al., Tumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8+ T Cells in Mice With Colitis, Gastroenterology, vol.149, pp.993-1005, 2015.

O. S. Qureshi, Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti et al., Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4, Science, vol.332, pp.600-603, 2011.

N. Rajan and J. A. Langtry, Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas, Clin. Exp. Dermatol, vol.31, pp.140-141, 2006.

V. Ramirez-carrozzi, A. Sambandam, E. Luis, Z. Lin, S. Jeet et al., IL-17C regulates the innate immune function of epithelial cells in an autocrine manner, Nat. Immunol, vol.12, pp.1159-1166, 2011.

S. Ranjbar, R. Rajsbaum, and A. E. Goldfeld, Transactivator of transcription from HIV type 1 subtype E selectively inhibits TNF gene expression via interference with chromatin remodeling of the TNF locus, J. Immunol. Baltim. Md, vol.176, pp.4182-4190, 1950.

S. Rantapää-dahlqvist, B. A. De-jong, E. Berglin, G. Hallmans, G. Wadell et al., Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis, Arthritis Rheum, vol.48, pp.2741-2749, 2003.

K. Raza, F. Falciani, S. J. Curnow, E. J. Ross, C. Lee et al., Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin, Arthritis Res. Ther, vol.7, pp.784-795, 2005.

M. Remberger, O. Ringden, and L. Markling, TNF alpha levels are increased during bone marrow transplantation conditioning in patients who develop acute GVHD, Bone Marrow Transplant, vol.15, pp.99-104, 1995.

D. K. Rhee, J. Marcelino, M. Baker, Y. Gong, P. Smits et al., The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth, J. Clin. Invest, vol.115, pp.622-631, 2005.

M. A. Rivas, R. P. Carnevale, C. J. Proietti, C. Rosemblit, W. Beguelin et al., TNF? acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-?B-dependent pathways, Exp. Cell Res, vol.314, pp.509-529, 2008.

M. Rodríguez, L. Cabal-hierro, M. T. Carcedo, J. M. Iglesias, N. Artime et al., NF-kappaB signal triggering and termination by tumor necrosis factor receptor 2, J. Biol. Chem, vol.286, pp.22814-22824, 2011.

M. G. Roncarolo, S. Gregori, R. Bacchetta, and M. Battaglia, Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications, Curr. Top. Microbiol. Immunol, vol.380, pp.39-68, 2014.

M. Rossol, U. Meusch, M. Pierer, S. Kaltenhauser, H. Hantzschel et al., Interaction between Transmembrane TNF and TNFR1/2 Mediates the Activation of Monocytes by Contact with T Cells, J. Immunol, vol.179, pp.4239-4248, 2007.

M. Rothe, V. Sarma, V. M. Dixit, and D. V. Goeddel, TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40, Science, vol.269, pp.1424-1427, 1995.

B. M. Rothschild, K. R. Turner, and M. A. Deluca, Symmetrical erosive peripheral polyarthritis in the Late Archaic Period of Alabama, Science, vol.241, pp.1498-1501, 1988.

M. Ryba, K. Rybarczyk-kapturska, K. Zorena, M. My?liwiec, and J. My?liwska, Lower frequency of CD62L(high) and higher frequency of TNFR2(+) Tregs are associated with inflammatory conditions in type 1 diabetic patients, Mediators Inflamm, p.645643, 2011.

S. Sakaguchi, K. Fukuma, K. Kuribayashi, and T. Masuda, Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease, J. Exp. Med, vol.161, pp.72-87, 1985.

S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic selftolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25), J. Immunol. Baltim. Md, vol.155, pp.1151-1164, 1950.

D. M. Sandoval, G. S. Alarcón, and S. L. Morgan, Adverse events in methotrexatetreated rheumatoid arthritis patients, Br. J. Rheumatol, vol.34, issue.2, pp.49-56, 1995.

L. L. Santos, E. F. Morand, P. Hutchinson, N. W. Boyce, and S. R. Holdsworth, Antineutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis, Clin. Exp. Immunol, vol.107, pp.248-253, 1997.

S. P. Sasi, J. Song, D. Park, H. Enderling, J. T. Mcdonald et al., TNF-TNFR2/p75 signaling inhibits early and increases delayed nontargeted effects in bone marrow-derived endothelial progenitor cells, J. Biol. Chem, vol.289, pp.14178-14193, 2014.

N. Sattar and I. B. Mcinnes, Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions, Curr. Opin. Rheumatol, vol.17, pp.286-292, 2005.

G. Schett and E. Gravallese, Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment, Nat. Rev. Rheumatol, vol.8, pp.656-664, 2012.

G. Schett, K. Redlich, Q. Xu, P. Bizan, M. Gröger et al., Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs, J. Clin. Invest, vol.102, pp.302-311, 1998.

J. Schiffenbauer, W. J. Streit, E. Butfiloski, M. Labow, C. Edwards et al., The Induction of EAE Is Only Partially Dependent on TNF Receptor Signaling but Requires the IL-1 Type I Receptor, Clin. Immunol, vol.95, pp.117-123, 2000.

S. M. Schlenner, B. Weigmann, Q. Ruan, Y. Chen, and H. Boehmer, Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut, J. Exp. Med, vol.209, pp.1529-1535, 2012.

T. Schmid, L. Falter, S. Weber, N. Müller, K. Molitor et al., Chronic Inflammation Increases the Sensitivity of Mouse Treg for TNFR2 Costimulation, Front. Immunol, vol.8, 2017.

R. Seibl, T. Birchler, S. Loeliger, J. P. Hossle, R. E. Gay et al., Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium, Am. J. Pathol, vol.162, pp.1221-1227, 2003.

T. M. Seyler, Y. W. Park, S. Takemura, R. J. Bram, P. J. Kurtin et al., BLyS and APRIL in rheumatoid arthritis, J. Clin. Invest, vol.115, pp.3083-3092, 2005.

S. Shibata, Y. Tada, Y. Asano, K. Yanaba, M. Sugaya et al., IL-27 Activates Th1-Mediated Responses in Imiquimod-Induced Psoriasis-Like Skin Lesions, J. Invest. Dermatol, vol.133, pp.479-488, 2013.

A. Singer, S. Adoro, and J. Park, Lineage fate and intense debate: myths, models and mechanisms of CD4-versus CD8-lineage choice, Nat. Rev. Immunol, vol.8, pp.788-801, 2008.

J. A. Singh, R. Christensen, G. A. Wells, M. E. Suarez-almazor, R. Buchbinder et al., A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview, CMAJ Can. Med. Assoc. J. J. Assoc. Medicale Can, vol.181, pp.787-796, 2009.

M. R. Slowik, L. G. De-luca, W. Fiers, and J. S. Pober, Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration, Am. J. Pathol, vol.143, pp.1724-1730, 1993.

J. S. Smolen, J. Kay, M. K. Doyle, R. Landewé, E. L. Matteson et al., Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial, Lancet Lond. Engl, vol.374, pp.210-221, 2009.

C. Sohn, A. Lee, Y. Qiao, K. Loupasakis, L. B. Ivashkiv et al., Prolonged tumor necrosis factor ? primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin, Arthritis Rheumatol. Hoboken NJ, vol.67, pp.86-95, 2015.

D. H. Solomon, E. W. Karlson, E. B. Rimm, C. C. Cannuscio, L. A. Mandl et al., Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis, Circulation, vol.107, pp.1303-1307, 2003.

R. Strohal, S. Chimenti, G. A. Vena, and G. Girolomoni, Etanercept provides an effective, safe and flexible short-and long-term treatment regimen for moderate-to-severe psoriasis: a systematic review of current evidence, J. Dermatol. Treat, vol.24, pp.199-208, 2013.

J. M. Stuart and F. J. Dixon, Serum transfer of collagen-induced arthritis in mice, J. Exp. Med, vol.158, pp.378-392, 1983.

H. Sugiyama, R. Gyulai, E. Toichi, E. Garaczi, S. Shimada et al., Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation, J. Immunol. Baltim. Md, vol.174, pp.164-173, 1950.

S. Sultana, R. Dey, and B. Bishayi, Dual neutralization of TNFR-2 and MMP-2 regulates the severity of <Emphasis Type="Italic">S. aureus</Emphasis> induced septic arthritis correlating alteration in the level of interferon gamma and interleukin-10 in terms of TNFR2 blocking, Immunol. Res, pp.1-23, 2017.

H. Suzuki, B. Wang, G. M. Shivji, P. Toto, P. Amerio et al., Imiquimod, a topical immune response modifier, induces migration of Langerhans cells, J. Invest. Dermatol, vol.114, pp.135-141, 2000.

D. P. Symmons, C. R. Bankhead, B. J. Harrison, P. Brennan, E. M. Barrett et al., Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident casecontrol study in, Arthritis Rheum, vol.40, pp.1955-1961, 1997.

S. K. Szabo, C. Hammerberg, Y. Yoshida, Z. Bata-csorgo, and K. D. Cooper, , 1998.

, Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets, J. Invest. Dermatol, vol.111, pp.1072-1078

Y. Tada, A. Ho, S. Koarada, F. Morito, O. Ushiyama et al., Collagen-Induced Arthritis in TNF Receptor-1-Deficient Mice: TNF Receptor-2 Can Modulate Arthritis in the Absence of TNF Receptor-1, Clin. Immunol, vol.99, pp.325-333, 2001.

X. Tai, F. Van-laethem, L. Pobezinsky, T. Guinter, S. O. Sharrow et al., Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells, Blood, vol.119, pp.5155-5163, 2012.

T. Takahashi, Y. Kuniyasu, M. Toda, N. Sakaguchi, M. Itoh et al., Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state, Int. Immunol, vol.10, pp.1969-1980, 1998.

T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu et al., Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4, J. Exp. Med, vol.192, pp.303-310, 2000.

S. Tanaka, Regulation of bone destruction in rheumatoid arthritis through RANKL-RANK pathways, World J. Orthop, vol.4, pp.1-6, 2013.

Y. Tanaka, M. Mola, and E. , IL-6 targeting compared to TNF targeting in rheumatoid arthritis: studies of olokizumab, sarilumab and sirukumab, Ann. Rheum. Dis, vol.73, pp.1595-1597, 2014.

G. A. Taylor, E. Carballo, D. M. Lee, W. S. Lai, M. J. Thompson et al., A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin, TTP) deficiency. Immunity, vol.4, pp.445-454, 1996.

T. Tenev, K. Bianchi, M. Darding, M. Broemer, C. Langlais et al., The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs, Mol. Cell, vol.43, pp.432-448, 2011.

A. Thiolat, L. Semerano, Y. M. Pers, J. Biton, D. Lemeiter et al., Interleukin-6 Receptor Blockade Enhances CD39+ Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis, Arthritis Rheumatol, vol.66, pp.273-283, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01870438

A. M. Thornton, E. E. Donovan, C. A. Piccirillo, and E. M. Shevach, Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function, J. Immunol. Baltim. Md, vol.172, pp.6519-6523, 1950.

A. Toker, D. Engelbert, G. Garg, J. K. Polansky, S. Floess et al., Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus, J. Immunol. Baltim. Md, pp.3180-3188, 2013.

H. Torrey, J. Butterworth, T. Mera, Y. Okubo, L. Wang et al., Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs, Sci Signal, vol.10, p.8608, 2017.

D. E. Trentham, A. S. Townes, and A. H. Kang, Autoimmunity to type II collagen an experimental model of arthritis, J. Exp. Med, vol.146, pp.857-868, 1977.

G. C. Tsokos, Immunomodulatory treatment in patients with rheumatic diseases: mechanisms of action, Semin. Arthritis Rheum, vol.17, pp.24-38, 1987.

A. V. Tsytsykova, R. Rajsbaum, J. V. Falvo, F. Ligeiro, S. R. Neely et al., , 2007.

, Activation-dependent intrachromosomal interactions formed by the TNF gene promoter and two distal enhancers, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.16850-16855

R. Tuma, M. Russell, M. Rosendahl, and G. J. Thomas, Solution conformation of the extracellular domain of the human tumor necrosis factor receptor probed by Raman and UVresonance Raman spectroscopy: structural effects of an engineered PEG linker, Biochemistry (Mosc.), vol.34, pp.15150-15156, 1995.

E. Turkstra, S. Ng, and P. A. Scuffham, A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis, Curr. Med. Res. Opin, vol.27, pp.1885-1897, 2011.

C. Tzimas, G. Michailidou, M. Arsenakis, E. Kieff, G. Mosialos et al., Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-kappaB, Cell. Signal, vol.18, pp.83-92, 2006.

J. B. Van-der-meer, E. J. Glazenburg, P. G. Mulder, H. F. Eggink, and P. J. Coenraads, The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group, Br. J. Dermatol, vol.140, pp.1114-1121, 1999.

N. Vanlangenakker, M. J. Bertrand, P. Bogaert, P. Vandenabeele, V. Berghe et al.,

, TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members, Cell Death Dis, vol.2, p.230

S. Vasudevan, Y. Tong, and J. A. Steitz, Switching from repression to activation: microRNAs can up-regulate translation, Science, vol.318, pp.1931-1934, 2007.

D. Venkatesh, T. Ernandez, F. Rosetti, I. Batal, X. Cullere et al., TNF receptor 2 induces IRF1 transcription factor-dependent interferon-? autocrine signaling to promote monocyte recruitment, Immunity, vol.38, pp.1025-1037, 2013.

T. L. Wagner, C. L. Ahonen, A. M. Couture, S. J. Gibson, R. L. Miller et al., Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod, Cell. Immunol, vol.191, pp.10-19, 1999.

H. Waldmann, E. Adams, and S. Cobbold, Reprogramming the immune system: coreceptor blockade as a paradigm for harnessing tolerance mechanisms, Immunol. Rev, vol.223, pp.361-370, 2008.

C. Wang, L. Deng, M. Hong, G. R. Akkaraju, J. Inoue et al., TAK1 is a ubiquitin-dependent kinase of MKK and IKK, Nature, vol.412, pp.346-351, 2001.

H. Wang, T. Peters, A. Sindrilaru, D. Kess, T. Oreshkova et al., TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis, J. Clin. Invest, vol.118, pp.2629-2639, 2008.

L. Wang, F. Du, W. , and X. , TNF-alpha induces two distinct caspase-8 activation pathways, Cell, vol.133, pp.693-703, 2008.

L. Wang, Y. Liu, R. Han, U. H. Beier, R. M. Thomas et al., , 2013.

, Mbd2 promotes foxp3 demethylation and T-regulatory-cell function, Mol. Cell. Biol, vol.33, pp.4106-4115

L. Wang, S. Kumar, S. Dahiya, F. Wang, J. Wu et al., Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3+ T-regulatory Cell Function and Promotes Antitumor Immunity, EBioMedicine, vol.13, pp.99-112, 2016.

C. F. Ware, P. D. Crowe, T. L. Vanarsdale, J. L. Andrews, M. H. Grayson et al., Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells, J. Immunol. Baltim. Md, vol.147, pp.4229-4238, 1950.

N. Wegner, R. Wait, A. Sroka, S. Eick, K. Nguyen et al., Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and ?-enolase: implications for autoimmunity in rheumatoid arthritis, Arthritis Rheum, vol.62, pp.2662-2672, 2010.

S. Wei, H. Kitaura, P. Zhou, F. P. Ross, and S. L. Teitelbaum, IL-1 mediates TNFinduced osteoclastogenesis, J. Clin. Invest, vol.115, pp.282-290, 2005.

C. M. Weyand and J. J. Goronzy, Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition, J. Clin. Invest, vol.85, pp.1051-1057, 1990.

R. S. Wildin, F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova et al., X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy, Nat. Genet, vol.27, pp.18-20, 2001.

S. K. Williams, O. Maier, R. Fischer, R. Fairless, S. Hochmeister et al., Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis, PLoS ONE, vol.9, p.90117, 2014.

F. Wolfe, The curious case of intramuscular gold, Rheum. Dis. Clin. North Am, vol.19, pp.173-187, 1993.

C. Wu, D. B. Conze, X. Li, S. Ying, J. A. Hanover et al., TNF-alpha induced c-IAP1/TRAF2 complex translocation to a Ubc6-containing compartment and TRAF2 ubiquitination, EMBO J, vol.24, pp.1886-1898, 2005.

X. Xu, L. Blinder, J. Shen, H. Gong, A. Finnegan et al., In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice, J. Immunol. Baltim. Md, vol.159, pp.167-174, 1950.

F. Yan, R. Du, F. Wei, H. Zhao, J. Yu et al., Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients, Cancer Immunol. Immunother, vol.64, pp.1475-1485, 2015.

Y. Yao, J. Vent-schmidt, M. D. Mcgeough, M. Wong, H. M. Hoffman et al., Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10-Dependent Mechanism, J. Immunol. Baltim. Md, pp.488-497, 2015.

A. Yarilina, K. Park-min, T. Antoniv, X. Hu, and L. B. Ivashkiv, TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes, Nat. Immunol, vol.9, pp.378-387, 2008.

N. Yawalkar, G. G. Tscharner, R. E. Hunger, and A. S. Hassan, Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis, J. Dermatol. Sci, vol.54, pp.99-105, 2009.

L. C. Zaba, I. Cardinale, P. Gilleaudeau, M. Sullivan-whalen, M. Suárez-fariñas et al., , 2007.

, Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses, J. Exp. Med, vol.204, pp.3183-3194

K. Zhang, X. Li, G. Yin, Y. Liu, X. Niu et al., Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder, Br. J. Dermatol, vol.158, pp.298-305, 2008.

P. Zhang, Y. Su, M. Zhao, W. Huang, and Q. Lu, Abnormal histone modifications in PBMCs from patients with psoriasis vulgaris, Eur. J. Dermatol. EJD, vol.21, pp.552-557, 2011.

Q. Zhang, F. Cui, L. Fang, J. Hong, B. Zheng et al., TNF-? impairs differentiation and function of TGF-?-induced Treg cells in autoimmune diseases through Akt and Smad3 signaling pathway, J. Mol. Cell Biol, vol.5, pp.85-98, 2013.

X. Zhang, W. Huang, S. Yang, L. Sun, F. Zhang et al., Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21, Nat. Genet, vol.41, pp.205-210, 2009.

X. Zhao, L. Rong, X. Zhao, X. Li, X. Liu et al.,

, TNF signaling drives myeloid-derived suppressor cell accumulation, J. Clin. Invest, vol.122, pp.4094-4104

L. Zheng, N. Bidere, D. Staudt, A. Cubre, J. Orenstein et al., Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1, Mol. Cell. Biol, vol.26, pp.3505-3513, 2006.

Y. Zheng, D. M. Danilenko, P. Valdez, I. Kasman, J. Eastham-anderson et al., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis, Nature, vol.445, pp.648-651, 2007.

Y. Zheng, A. Chaudhry, A. Kas, P. Deroos, J. M. Kim et al., Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses, Nature, vol.458, pp.351-356, 2009.

Y. Zheng, S. Josefowicz, A. Chaudhry, X. P. Peng, K. Forbush et al., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate, Nature, vol.463, pp.808-812, 2010.

J. Zhu, T. S. Davidson, G. Wei, D. Jankovic, K. Cui et al., Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells, J. Exp. Med, vol.206, pp.329-341, 2009.

M. Zimmermann, F. B. Aguilera, M. Castellucci, M. Rossato, S. Costa et al., Chromatin remodelling and autocrine TNF? are required for optimal interleukin-6 expression in activated human neutrophils, Nat. Commun, vol.6, p.6061, 2015.

R. J. Zitnik and J. A. Cooper, Pulmonary disease due to antirheumatic agents, Clin. Chest Med, vol.11, pp.139-150, 1990.